Levothyroxine Sodium Injection, Powder, Lyophilized, For Solution
NDC 70771-1818
Product Information
Levothyroxine Sodium is a ANDA-approved product labeled by Zydus Lifesciences Limited. This medication is typically used as a thyroxine [cs]. It is supplied as a white injection, powder, lyophilized, for solution for intravenous administration. This product entry covers the primary NDC 70771-1818 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 70771-1818?
What are Active Ingredients of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LEVOTHYROXINE SODIUM ANHYDROUS (UNII: 054I36CPMN)
- LEVOTHYROXINE (UNII: Q51BO43MG4) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MANNITOL (UNII: 3OWL53L36A)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1115267 - levothyroxine sodium 100 MCG Injection
- RxCUI: 1115267 - levothyroxine sodium 0.1 MG Injection
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.